Literature DB >> 9332452

Two pathways for insulin metabolism in adipocytes.

W C Duckworth1, F G Hamel, D E Peavy.   

Abstract

Using selected conditions, the appropriate collagenase, albumin and cell treatment, a preparation of isolated adipocytes was developed with no extracellular insulin degrading activity. Cell mediated insulin degradation rates were 0.68% +/- 0.05%/100,000 cell/h using trichloracetic acid precipitability as a measure. Chloroquine (CQ) increased cell-associated radioactivity and decreased degradation while dansylcadaverine (DC), PCMBS and bacitracin (BAC) decreased degradation with no effect on binding. Extraction and chromatography of the cell-associated radioactivity showed 3 peaks, a large molecular weight peak, a small molecular weight peak and an insulin-sized peak. CQ, DC and BAC all decreased the small molecular weight peak while CQ and DC also increased the peak of large molecular weight radioactivity. Cell mediated insulin degradation in the presence of combinations of inhibitors suggested two pathways in adipocytes, one affected by inhibitors of the insulin degrading enzyme (IDE) (bacitracin and PCMBS) and the other altered by cell processing inhibitors (DC, CQ and phenylarsenoxide). Chloroquine altered the pattern of the insulin-sized cell-associated HPLC assayed degradation products, further supporting two pathways of degradation; one a chloroquine-sensitive and one a chloroquine-insensitive pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9332452     DOI: 10.1016/s0167-4889(97)00066-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo.

Authors:  Timothy B Durham; James L Toth; Valentine J Klimkowski; Julia X C Cao; Angela M Siesky; Jesline Alexander-Chacko; Ginger Y Wu; Jeffrey T Dixon; James E McGee; Yong Wang; Sherry Y Guo; Rachel Nicole Cavitt; John Schindler; Stefan J Thibodeaux; Nathan A Calvert; Michael J Coghlan; Dana K Sindelar; Michael Christe; Vladislav V Kiselyov; M Dodson Michael; Kyle W Sloop
Journal:  J Biol Chem       Date:  2015-06-17       Impact factor: 5.157

2.  Hexosamine biosynthesis impairs insulin action via a cholesterolgenic response.

Authors:  Brent A Penque; April M Hoggatt; B Paul Herring; Jeffrey S Elmendorf
Journal:  Mol Endocrinol       Date:  2013-01-11

3.  Insulin inhibition of protein degradation in cells expressing wild-type and mutant insulin receptors.

Authors:  F G Hamel; J Fawcett; C I Andersen; P Berhanu; R G Bennett; W C Duckworth
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

4.  Single-cell profiling reveals the origin of phenotypic variability in adipogenesis.

Authors:  Thuc T Le; Ji-Xin Cheng
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

5.  Bacitracin attenuates haemolysis-induced insulin degradation during insulin sensitivity testing: Repurposing an old drug for use in metabolic research.

Authors:  Andrew P Demidowich; Jordan A Levine; Sheila M Brady; Cheryl D Johnson; Steven J Soldin; Jack A Yanovski
Journal:  Diabetes Obes Metab       Date:  2020-04-20       Impact factor: 6.408

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.